Axsome expands sales force to support launch of fast-growing depression med Auvelity

With revenue on the rise for its fast-working depression med Auvelity, Axsome Therapeutics is in the process of boosting its sales force with nearly 100 new hires.

The company’s previously divulged expansion from 162 to 260 Auvelity sales reps is underway and should be completed during this year's fourth quarter, Axsome said in its third-quarter earnings release.